Access Bio Signs Supply Contract for COVID-19 Diagnostic Kit Raw Materials Worth 46.9 Billion KRW
[Asia Economy Reporter Junho Hwang] Access Bio announced on the 23rd that it has signed a raw material supply contract for COVID-19 antigen test kits with Apacor. The contract amount is 46.9176 billion KRW, which corresponds to 38.51% of the 2020 sales. The contract period is until May 7.
Hot Picks Today
!["It Has Finally Crossed Borders"... Greater Fear Due to Delayed Detection, No Treatment for Variant Ebola [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Finally Crossed Borders"... Greater Fear Due to Delayed Detection, No Treatment for Variant Ebola [Reading Science]
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
